Source-grounded facts extracted from Aimei Health Technology Co., Ltd.'s SEC 8-K filings across all families, newest first. Each cites a verbatim SEC excerpt.
Aimei Health Technology Co., Ltd. received a nasdaq deficiency notice notice regarding late filing (rules 5250(c)(1)).
“May 19, 2026, Aimei Health Technology Co., Ltd (the “ Company ”) received a notice (the “ Notice ”) from the Listing Qualifications Department (the “ Staff ”) of The Nasdaq Stock Market LLC (“ Nasdaq ”), notifying the Co”
Aimei Health Technology Co., Ltd. incurred loan of $34,330.96 with Aimei Health Ltd and United Hydrogen Group Inc. at does not bear interest maturing upon the date on which the Company consummates a business combination with United Hydrogen.
“the Company issued, on May 6, 2026, an unsecured promissory note in the total principal amount of $34,330.96 (the “ Promissory Note ”) to Aimei Health Ltd, a Cayman Islands exempted company (the “ Sponsor ”) and United Hydrogen Group Inc., an exempted company with limited liability incorporated in the Cayman Islands”
Aimei Health Technology Co., Ltd. received a nasdaq deficiency notice notice regarding late filing (rules 5250(c)(1)).
“April 17, 2026, Aimei Health Technology Co., Ltd (the “ Company ”) received a notice (the “ Notice ”) from the Listing Qualifications Department (the “ Staff ”) of The Nasdaq Stock Market LLC (“ Nasdaq ”), notifying the Company that because the Company had not yet filed its Annual Report on Form 10-K for the fiscal year ended December 31, 2025 (the “ Annual Report ”), the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1) (the “Listing Rule”) requiring Nasdaq-listed companies to timely file all periodic financial reports with the U.S. Securities and Exchange Commission (the “ SEC”
Aimei Health Technology Co., Ltd. incurred loan of $34,330.96 with Aimei Health Ltd and United Hydrogen Group Inc. at does not bear interest maturing upon the date on which the Company consummates a business combination with United Hydrogen.
“the Company issued, on April 7, 2026, an unsecured promissory note in the total principal amount of $34,330.96”
Aimei Health Technology Co., Ltd. incurred loan of $34,330.96 with Aimei Health Ltd and United Hydrogen Group Inc. at does not bear interest maturing upon the date on which the Company consummates a business combination with United Hydrogen.
“the Company issued, on March 4, 2026, an unsecured promissory note in the total principal amount of $34,330.96 (the “ Promissory Note ”) to Aimei Health Ltd, a Cayman Islands exempted company (the “ Sponsor ”) and United Hydrogen Group Inc., an exempted company with limited liability incorporated in the Cayman Islands”
Aimei Health Technology Co., Ltd. incurred loan of $34,330.96 with Aimei Health Ltd and United Hydrogen Group Inc. at does not bear interest maturing due and payable upon the date on which the Company consummates a business combination.
“the Company issued, on February 12, 2026, an unsecured promissory note in the total principal amount of $34,330.96 (the “ Promissory Note ”) to Aimei Health Ltd, a Cayman Islands exempted company (the “ Sponsor ”) and United Hydrogen Group Inc., an exempted company with limited liability incorporated in the Cayman Islands”
Aimei Health Technology Co., Ltd. incurred loan of $34,330.96 with Aimei Health Ltd (Sponsor) and United Hydrogen Group Inc. at does not bear interest maturing upon the date on which the Company consummates a business combination with United Hydrogen.
“the Company issued, on January 5, 2026, an unsecured promissory note in the total principal amount of $34,330.96”
Aimei Health Technology Co., Ltd. amended Trust Agreement Amendment with Continental Stock Transfer & Trust Company.
“Trust Agreement Amendment As approved by its shareholders at the Extraordinary General Meeting (defined below), Aimei Health Technology Co., Ltd (the “ Company ”) entered into an amendment (the “ Trust Agreement Amendment ”) to the Investment Management Trust Agreement, dated December 1, 2023 (the “ Trust Agreement ”), with Continental Stock Transfer & Trust Company, as trustee (“ Trustee ”).”
Aimei Health Technology Co., Ltd.: Amended Article 35.2 of the Articles of Association to extend the business combination deadline from 24 to 36 months after the IPO, i.e., to December 6, 2026 (effective 2025-11-26).
“Article 35.2 of the Amended and Restated Articles of Association of the Company, as in effect immediately prior to the Extraordinary General Meeting, was amended and restated to essentially extend the date by which the Company has to consummate a business combination from 24 months from the date of the Company’s initial public offering (namely, December 6, 2025) to 36 months from the date of the Company’s initial public offering (namely, December 6, 2026).”
Aimei Health Technology Co., Ltd. incurred loan of $150,000 total, equally divided ($75,000 each) with Aimei Health Ltd (Sponsor) and United Hydrogen Group Inc. at does not bear interest maturing due and payable upon consummation of the Business Combination.
“In connection with the Extension, the Company issued, on November 4, 2025 , an unsecured promissory note in the total principal amount of $150,000 (the “ Promissory Note ”) to Aimei Health Ltd, a Cayman Islands exempted company (the “ Sponsor ”) and United Hydrogen Group Inc., an exempted company with limited liability incorporated in the Cayman Islands (“ United Hydrogen ,” and together with the Sponsor, the “ Payees ”).”
Aimei Health Technology Co., Ltd. incurred loan of $150,000 with Aimei Health Ltd and United Hydrogen Group Inc. at does not bear interest maturing upon the date on which the Company consummates a business combination.
“the Company issued, on September 5, 2025, an unsecured promissory note in the total principal amount of $150,000”
Aimei Health Technology Co., Ltd. incurred loan of $150,000 with Aimei Health Ltd and United Hydrogen Group Inc. at does not bear interest maturing upon the date on which the Company consummates a business combination with United Hydrogen.
“the Company issued, on August 6, 2025, an unsecured promissory note in the total principal amount of $150,000 (the “ Promissory Note ”) to Aimei Health Ltd”
Aimei Health Technology Co., Ltd. incurred loan of $150,000 with Aimei Health Ltd and United Hydrogen Group Inc. at does not bear interest maturing due and payable upon the date on which the Company consummates a business combination with United Hydrogen.
“In connection with the Extension, the Company issued, on June 6, 2025 , an unsecured promissory note in the total principal amount of $150,000 (the “ Promissory Note ”) to Aimei Health Ltd, a Cayman Islands exempted company (the “ Sponsor ”) and United Hydrogen Group Inc., an exempted company with limited liability incorporated in the Cayman Islands (“ United Hydrogen ,” and together with the Sponsor, the “ Payees ”).”
Aimei Health Technology Co., Ltd. incurred loan of $150,000 with Aimei Health Ltd and United Hydrogen Group Inc. at does not bear interest maturing due and payable upon the date on which the Company consummates a business combination with United Hydrogen.
“In connection with the Extension, the Company issued, on May 6, 2025, an unsecured promissory note in the total principal amount of $150,000 (the " Promissory Note ") to Aimei Health Ltd, a Cayman Islands exempted company (the " Sponsor ") and United Hydrogen Group Inc., an exempted company with limited liability incorporated in the Cayman Islands (" United Hydrogen ," and together with the Sponsor, the " Payees ").”
Aimei Health Technology Co., Ltd. incurred loan of $150,000 with Aimei Health Ltd and United Hydrogen Group Inc. at does not bear interest maturing due and payable upon the date on which the Company consummates a business combination with United Hydrogen.
“In connection with the Extension, the Company issued, on April 4, 2025, an unsecured promissory note in the total principal amount of $150,000 (the “ Promissory Note ”) to Aimei Health Ltd, a Cayman Islands exempted company (the “ Sponsor ”) and United Hydrogen Group Inc., an exempted company with limited liability incorporated in the Cayman Islands (“ United Hydrogen ,” and together with the Sponsor, the “ Payees ”).”
Aimei Health Technology Co., Ltd. incurred loan of $150,000 with Aimei Health Ltd and United Hydrogen Group Inc. at does not bear interest maturing upon the date on which the Company consummates a business combination with United Hydrogen.
“In connection with the Extension, the Company issued, on March 6, 2025, an unsecured promissory note in the total principal amount of $150,000 (the “ Promissory Note ”) to Aimei Health Ltd, a Cayman Islands exempted company (the “ Sponsor ”) and United Hydrogen Group Inc., an exempted company with limited liability incorporated in the Cayman Islands (“ United Hydrogen ,” and together with the Sponsor, the “ Payees ”). The amount was equally divided between the Payees, with each contributing $75,000, to fund the Extension Payment . The Promissory Note does not bear interest and the principal thereunder becomes due and payable upon the date on which the Company consummates a business combination with United Hydrogen (the “ Business Combination ”).”
Aimei Health Technology Co., Ltd.: Amendment to Article 35.2 of the Amended and Restated Articles of Association to add language regarding trust agreement amendments (effective 2025-02-06).
“Pursuant to the results of the Adjourned Meeting (defined below), Article 35.2 of the Amended and Restated Articles of Association of the Company, as in effect immediately prior to the Adjourned Meeting, was amended to insert the words “ , or, if such trust agreement has been amended, in that trust agreement, as amended from time to time, in accordance with its terms ” after the words “ and referred to in the Registration Statement ” in that Article.”
Junheng Xie was appointed as Chief Executive Officer, Secretary and director at Aimei Health Technology Co., Ltd..
“On April 19, 2024, the board of directors of the Company appointed Mr. Junheng Xie as the Chief Executive Officer, Secretary and a director of the Company with effect from April 15, 2024.”
Juan Fernandez Pascual resigned as Chief Executive Officer, Secretary and director at Aimei Health Technology Co., Ltd..
“On April 15, 2024, Juan Fernandez Pascual tendered to the board of directors of Aimei Health Technology Co., Ltd. (the “ Company ”) his resignation, effective as of that date, as Chief Executive Officer, Secretary and a director of the Company.”
Aimei Health Technology Co., Ltd.: Amended and Restated Memorandum and Articles of Association filed in connection with IPO (effective 2023-12-01).
“On December 1, 2023, in connection with the IPO, the Company filed its Amended and Restated Memorandum and Articles of Association.”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.